Reacta Healthcare Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 69

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.25M

  • Investors
  • 7

Reacta Healthcare General Information

Description

Manufacturer of clinically validated oral meals intended for allergy assessment purposes. The company's platform incorporates pharmaceutical-grade challenge materials, compliance with international regulatory standards, and structured protocols for oral food challenges, enabling healthcare providers and research institutions to accurately diagnose complex allergic conditions, improve patient safety, and support evidence-based treatment strategies through reproducible and standardized diagnostic procedures.

Contact Information

Formerly Known As
Reacta Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Newtech Square
  • Deeside Industrial Park
  • Deeside CH5 2NT
  • Wales, United Kingdom
+44 01244
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Diagnostic Equipment
Corporate Office
  • 2 Newtech Square
  • Deeside Industrial Park
  • Deeside CH5 2NT
  • Wales, United Kingdom
+44 01244

Reacta Healthcare Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reacta Healthcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Grant 17-May-2024 $1.25M Completed Generating Revenue
12. Later Stage VC 17-Nov-2023 Completed Generating Revenue
11. Grant 10-Feb-2023 Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Grant 27-Apr-2022 Completed Generating Revenue
8. Later Stage VC 14-Jul-2021 Completed Generating Revenue
7. Later Stage VC 02-Mar-2020 Completed Generating Revenue
6. Later Stage VC 11-Jul-2019 Completed Generating Revenue
5. Later Stage VC 20-Sep-2018 $443K $2.39M Completed Generating Revenue
4. Early Stage VC 19-Apr-2017 $250K $1.94M Completed Startup
To view Reacta Healthcare’s complete valuation and funding history, request access »

Reacta Healthcare Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 130,286 $0.001223 $8.56 $8.56 1x $8.56 6.63%
Ordinary 97,229 $0.001223 $3.98 $3.98 1x $3.98 4.95%
To view Reacta Healthcare’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Reacta Healthcare Patents

Reacta Healthcare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2950506-T3 Food formulations for oral food testing Active 05-Dec-2016
AU-2016431600-A1 Oral food challenge meal formulations Active 05-Dec-2016
AU-2016431600-B2 Oral food challenge meal formulations Active 05-Dec-2016
CA-3044905-A1 Oral food challenge meal formulations Active 05-Dec-2016
EP-3548079-A1 Oral food challenge meal formulations Active 05-Dec-2016 A61B5/411
To view Reacta Healthcare’s complete patent history, request access »

Reacta Healthcare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reacta Healthcare Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Biomedical Catalyst Government
Pxn Ventures Corporate Venture Capital Minority
Development Bank of Wales Growth/Expansion Minority
Perscitus Family Office Minority
You’re viewing 5 of 7 investors. Get the full list »

Reacta Healthcare FAQs

  • When was Reacta Healthcare founded?

    Reacta Healthcare was founded in 2013.

  • Where is Reacta Healthcare headquartered?

    Reacta Healthcare is headquartered in Deeside, United Kingdom.

  • What is the size of Reacta Healthcare?

    Reacta Healthcare has 69 total employees.

  • What industry is Reacta Healthcare in?

    Reacta Healthcare’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Reacta Healthcare a private or public company?

    Reacta Healthcare is a Private company.

  • What is Reacta Healthcare’s current revenue?

    The current revenue for Reacta Healthcare is .

  • How much funding has Reacta Healthcare raised over time?

    Reacta Healthcare has raised $11.6M.

  • Who are Reacta Healthcare’s investors?

    Innovate UK, Biomedical Catalyst, Pxn Ventures, Development Bank of Wales, and Perscitus are 5 of 7 investors who have invested in Reacta Healthcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process